Hutchmed (China) Limited (HCM) has released an update.
HUTCHMED (China) Limited has announced the appointment of Dr. Renu Bhatia as an Independent Non-executive Director and member of the Technical Committee, effective May 13, 2024. Dr. Bhatia brings over 25 years of experience in healthcare, finance, fintech, and regulatory sectors, enhancing the company’s board expertise. She holds notable positions such as chairman of the Listing Committee of The Stock Exchange of Hong Kong Limited and has a strong background in investment banking and asset management.
For further insights into HCM stock, check out TipRanks’ Stock Analysis page.
